Virax Biolabs Group Ltd Adjustments For Unrealised Foreign Exchange Losses Gains
Virax Biolabs Group Ltd (VRAX) reported Adjustments For Unrealised Foreign Exchange Losses Gains of $123.74 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains · last filed 2025-07-02
| Period end | Adjustments For Unrealised Foreign Exchange Losses Gains 12 month |
|---|---|
| 2025-03-31 | $123.74K 20-F · filed 2025-07-02 |
| 2024-03-31 | $3.67K 20-F · filed 2025-07-02 |
| 2023-03-31 | $111.00 20-F · filed 2025-07-02 |
| 2022-03-31 | $5.66K 20-F · filed 2024-08-20 |
| 2021-03-31 | -$3.87K 20-F · filed 2022-08-12 |